St Mark's Hospital is a hospital in Harrow, Greater London, England. Managed by London North West University Healthcare NHS Trust, it is the only hospital in the world to specialise entirely in intestinal ...

During the past decade, St. Mark's Hospital conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 6 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Mark's Hospital" #1 sponsor was "London North West Healthcare NHS Trust" with 11 trials, followed by "Shire" with 6 trials sponsored, "Imperial College London" with 3 trials sponsored, "S.L.A. Pharma AG" with 3 trials sponsored and "Norgine" with 3 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Mark's Hospital" #1 collaborator was "London North West Healthcare NHS Trust" with 2 trials as a collaborator, "University College London Hospitals" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Academic Medical Organization of Southwestern Ontario" with 1 trials as a collaborator and "Cosmo Technologies Ltd" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "St. Mark's Hospital" are "Ulcerative Colitis" (8 trials), "Short Bowel Syndrome" (7 trials), "Crohn's Disease" (6 trials), "Colorectal Cancer" (4 trials) and "Crohn Disease" (2 trials). Many other conditions were trialed in "St. Mark's Hospital" in a lesser frequency.

Most popular intervention types in "St. Mark's Hospital" are "Drug" (25 trials), "Procedure" (10 trials), "Other" (7 trials), "Diagnostic Test" (5 trials) and "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Narrow Band Imaging" (2 trials), "glepaglutide" (2 trials), "laboratory biomarker analysis" (2 trials) and "10% Metronidazole Ointment" (1 trials). Other intervention names were less common.

The vast majority of trials in "St. Mark's Hospital" are 49 trials for "All" genders.

Currently, there are NaN active trials in "St. Mark's Hospital". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in St. Mark's Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in St. Mark's Hospital, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 11 trials that are defined as “Not Applicable".